跳至主要内容
临床试验/CTRI/2023/06/054429
CTRI/2023/06/054429招募中4 期

Comparison of parenteral to oral split-dose methotrexate in terms of efficacy and intracellular methotrexate polyglutamate levels – A randomized controlled trial - SCOOTS

PGIMER0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
PGIMER

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.1. Meeting ACR/EULAR criteria 2010
  • 2. RF or Anti-CCP positive
  • 3. Given informed Consent
  • 4. Weight at least 40 kg
  • 5.TJC28 of atleast 6 AND SJC 28 of atleast 3
  • 6. Not in Class 4 functional status (fully dependant)
  • 7. Duration of RA of less than or equal to 3 years

排除标准

  • 1. Currently on methotrexate /leflunomide/ sulfasalzine or has received them in the last 3 months
  • 2. Taken JAKI in last 1 month
  • 3,. Taken biological agents (TNF inhibitors or rituximab in last 6 months)
  • 4. Pregnant/lactating OR planning pregnancy
  • 5. 5. IM Steroid in last 7 days or Oral Pred >10 mg/d
  • 6. Low blood counts (Hb <7, TLC <4000, Plt <100,000)
  • 7. Raised transaminases (SGOT or SGPT >50 IU/L)
  • 8. Creatinine >1.3mg/dL
  • 9. K/C/O Chronic liver disease
  • 10. K/C/O Chronic lung disease - bronchiectasis/ILD with FVC <70%
  • 11. HepB/Hep C/HIV +ve OR Active TB or other infections

研究者

发起方
PGIMER

相似试验